avapro has been researched along with Cancer of Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Chen, Y; Fu, L; Zhang, L | 1 |
| Christophi, C; Malcontenti-Wilson, C; Muralidharan, V; Neo, JH | 1 |
1 review(s) available for avapro and Cancer of Liver
| Article | Year |
|---|---|
Inhibiting Sodium Taurocholate Cotransporting Polypeptide in HBV-Related Diseases: From Biological Function to Therapeutic Potential.
Topics: Carcinoma, Hepatocellular; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Hepatocytes; Humans; Interferons; Liver Neoplasms; Nucleotides; Organic Anion Transporters, Sodium-Dependent; Symporters; Virus Internalization | 2022 |
1 other study(ies) available for avapro and Cancer of Liver
| Article | Year |
|---|---|
Effect of ACE inhibitors and angiotensin II receptor antagonists in a mouse model of colorectal cancer liver metastases.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Captopril; Colorectal Neoplasms; Disease Models, Animal; Irbesartan; Liver Neoplasms; Male; Mice; Mice, Inbred CBA; Microscopy, Electron, Scanning; Necrosis; Tetrazoles | 2007 |